Search results
FDA approves new tool to enhance cataract surgery outcomes
Medical Device Network via Yahoo Finance· 12 hours agoThe MDDT programme by the FDA aims to streamline the development process by providing pre-qualified...
What are alternatives to Ozempic and Wegovy and are they safe?
Medical Xpress· 3 hours agoThe copycat drugs are made by specialized pharmacies known as compounding pharmacies, which are allowed by the U.S. Food and Drug Administration to make off-label versions ...
Opinion | Want the best sunscreens this Memorial Day? The FDA is blocking you.
MSNBC via Yahoo News· 11 minutes agoAmericans visiting beaches in France, Spain or Italy can do something that’s illegal back home:...
FDA Approves Biosimilars for Macular Degeneration Treatment
Healthline via AOL· 5 days agoThe FDA approved two interchangeable biosimilars to treat macular degeneration. The biosimilars work...
Telix seeks prostate cancer imaging kit approval from FDA
Medical Device Network via Yahoo Finance· 12 hours agoThis kit will be used for the preparation...regulatory approval and expected to have extended...
Sanofi's (SNY) Sarclisa sBLA Gets FDA's Priority Review Tag
Zacks via Yahoo Finance· 6 hours agoThe FDA grants priority review to Sanofi's (SNY) sBLA for the Sarclisa combination regimen for...
What's the Difference Between Ozempic and Wegovy?
Health via Yahoo News· 4 hours agoOzempic and Wegovy are GLP-1 medications that aim to improve blood sugar and obesity. While these drugs are similar, they differ in effectiveness and...
FDA denies Ipsen's citizen petition for blockbuster drug Somatuline
Endpoints News· 3 days agoUS drug regulators have turned down Ipsen’s effort to slow down generic competition for its blockbuster drug Somatuline Depot, which is used to slow the ...
The most common myths about weight-loss drugs
WJZY via Yahoo News· 6 hours agoInjectable GLP-1 medications, like Ozempic, Mounjaro, Wegovy and Zepbound, have been the subject of a lot of excitement – some of it earned, some of it...
Hims & Hers will sell knock-off Ozempic for $199 — and it won’t be approved by FDA
NY Post via Yahoo Finance· 4 days agoThe demand for GLP-1 semaglutide far exceeds the current...Studio – stock.adobe.com The Hims version...
